Top 10 companies
Korenberg Matthew E
|
52 | |
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
|
49 | |
QLGN
Qualigen Therapeutics
|
3 |
Relative stock performance:
Search information
Ownership
Filing Types
Korenberg Matthew E
People
SEC filings
Source
By filing date (month)
By filing type
4 | 47 | |
144 | 2 | |
3 | 2 | |
144/A | 1 |